The diagnostic specificity of CEA and CA 19-9 is limited, since they exhibit alterations not only in patients with gastrointestinal cancer but also in individuals with other malignancies, including breast and lung cancer [8]. The gene discussed is CEACAM5; the disease is lung cancer.